iBio Announces Important Expansion of its Intellectual Property Portfolio: Allowance of Patent for Anthrax Vaccines and Further Application of Modulator Platform
03:45 EDT 18 Jun 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
NEWARK, Del., June 18, 2012 /PRNewswire/ -- iBio, Inc. (NYSE AMEX: IBIO) today announced that the US Patent Office has allowed patent application 11/706,576 entitled "Bacillus anthracis Antigens, Vaccine Compositions, and Related Methods." The c...
Other Sources for this Article
More From BioPortfolio on "iBio Announces Important Expansion of its Intellectual Property Portfolio: Allowance of Patent for Anthrax Vaccines and Further Application of Modulator Platform"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
